Literature DB >> 1419648

Sialyl Tn as a prognostic marker in epithelial ovarian cancer.

H Kobayashi, T Terao, Y Kawashima.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1992        PMID： 1419648      PMCID： PMC1977998          DOI： 10.1038/bjc.1992.397

Source DB:  PubMed          Journal:  Br J Cancer        ISSN： 0007-0920            Impact factor:   7.640


× No keyword cloud information.
  7 in total

1.  Tumor-associated mucin-type glycoprotein (CA54/61) defined by two monoclonal antibodies (MA54 and MA61) in ovarian cancers.

Authors:  S Nozawa; M Yajima; K Kojima; R Iizuka; H Mochizuki; T Sugawara; M Iwamori; Y Nagai
Journal:  Cancer Res       Date:  1989-01-15       Impact factor: 12.701

2.  Tumor antigen CA 125 as a marker of ovarian epithelial carcinoma.

Authors:  F Zanaboni; F Vergadoro; M Presti; P Gallotti; F Lombardi; G Bolis
Journal:  Gynecol Oncol       Date:  1987-09       Impact factor: 5.482

3.  Sialosyl-Tn. A novel mucin antigen associated with prognosis in colorectal cancer patients.

Authors:  S H Itzkowitz; E J Bloom; W A Kokal; G Modin; S Hakomori; Y S Kim
Journal:  Cancer       Date:  1990-11-01       Impact factor: 6.860

4.  Location and distribution of difucoganglioside (VI3NeuAcV3III3Fuc2nLc6) in normal and tumor tissues defined by its monoclonal antibody FH6.

Authors:  Y Fukushi; R Kannagi; S Hakomori; T Shepard; B G Kulander; J W Singer
Journal:  Cancer Res       Date:  1985-08       Impact factor: 12.701

5.  Clinical evaluation of circulating serum sialyl Tn antigen levels in patients with epithelial ovarian cancer.

Authors:  H Kobayashi; T Terao; Y Kawashima
Journal:  J Clin Oncol       Date:  1991-06       Impact factor: 44.544

6.  The CA 125 assay as a predictor of clinical recurrence in epithelial ovarian cancer.

Authors:  J M Niloff; R C Knapp; P T Lavin; G D Malkasian; J S Berek; R Mortel; C Whitney; V R Zurawski; R C Bast
Journal:  Am J Obstet Gynecol       Date:  1986-07       Impact factor: 8.661

7.  A radioimmunoassay using a monoclonal antibody to monitor the course of epithelial ovarian cancer.

Authors:  R C Bast; T L Klug; E St John; E Jenison; J M Niloff; H Lazarus; R S Berkowitz; T Leavitt; C T Griffiths; L Parker; V R Zurawski; R C Knapp
Journal:  N Engl J Med       Date:  1983-10-13       Impact factor: 91.245
  7 in total
  3 in total

Review 1.  The Role of Sialyl-Tn in Cancer.

Authors:  Jennifer Munkley
Journal:  Int J Mol Sci       Date:  2016-02-24       Impact factor: 5.923

Review 2.  The role of glycans in the development and progression of prostate cancer.

Authors:  Jennifer Munkley; Ian G Mills; David J Elliott
Journal:  Nat Rev Urol       Date:  2016-04-19       Impact factor: 14.432

Review 3.  Hallmarks of glycosylation in cancer.

Authors:  Jennifer Munkley; David J Elliott
Journal:  Oncotarget       Date:  2016-06-07
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.